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ABSTRACT
Phylodynamic techniques combine epidemiological
and genetic information to analyze the evolutionary
and spatiotemporal dynamics of rapidly evolving
pathogens, such as influenza A or human immuno-
deficiency viruses. We introduce ‘allele dynamics
plots’ (AD plots) as a method for visualizing the evo-
lutionary dynamics of a gene in a population. Using
AD plots, we propose how to identify the alleles that
are likely to be subject to directional selection. We
analyze the method’s merits with a detailed study of
the evolutionary dynamics of seasonal influenza A
viruses. AD plots for the major surface protein
of seasonal influenza A (H3N2) and the 2009
swine-origin influenza A (H1N1) viruses show the
succession of substitutions that became fixed in
the evolution of the two viral populations. They
also allow the early identification of those viral
strains that later rise to predominance, which is im-
portant for the problem of vaccine strain selection.
In summary, we describe a technique that reveals
the evolutionary dynamics of a rapidly evolving
population and allows us to identify alleles and
associated genetic changes that might be under dir-
ectional selection. The method can be applied for
the study of influenza A viruses and other rapidly
evolving species or viruses.
INTRODUCTION
Phylogenetic analysis allows the inference of evolutionary
relationships from a set of genetic sequences, which may
represent a distinct species or a genetic region of individ-
uals of a population. For populations of rapidly evolving
organisms, the evolutionary and epidemiological processes
may occur on similar timescales. Newly developed analyt-
ical methods, known as phylodynamic techniques, allow
the joint analysis of the genetic and epidemiological rela-
tionships of the underlying data (1,2). Based on epidemio-
logical information, such as sampling locations or
sampling times, phylodynamic methods enable the geo-
graphic migration patterns of individuals of a population
to be studied, tracking viral spread across host tissues,
searching for genetic sites subject to purifying or positive
selection associated with adaptation, dating past evolu-
tionary events and gaining insights into population-level
processes using coalescence analysis. In (3), for example,
the migration paths of the highly pathogenic avian
inﬂuenza A (H5N1) virus across Asia are inferred with a
‘phylogeographic’ approach from genetic sequences and
geographic sampling locations. Other studies revealed
that chimpanzees serve as a natural reservoir for
pandemic and nonpandemic HIV type 1 (4), based
on ‘phylogeographic’ clustering, and identiﬁed the
epidemic history and geographic source of HIV type 2
based on a molecular clock analysis of dated genetic
sequences (5).
We describe a method for analyzing the population-
level phylodynamics of a gene, which we call allele
dynamics plots (AD plots). AD plots combine informa-
tion from phylogenetic inference and ancestral character
state reconstruction with isolate sampling times for the
analysis of population-level evolutionary dynamics.
Furthermore, we use the AD plot of a population-level
sequence sample to identify the alleles that might be
associated with a selective advantage. Based on this, we
demonstrate how AD plots can be used to study evolu-
tionary dynamics and to identify emerging viral strains
with the example of two inﬂuenza A viruses: the human
inﬂuenza A (H3N2) and the 2009 swine-origin inﬂuenza A
(H1N1) viruses.
In research into the evolution of the inﬂuenza virus, a
method that enables the identiﬁcation of alleles under se-
lection is to count the number of amino acid changes
within a protein at sites under selection, which, in turn,
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to-synonymous mutations (dN/dS) (6). A recent study
suggests, however, that dN/dS ratios may not always be
informative with regards to detecting selection within a
population. Moreover, the method is lacking in sensitivity
when applied to individual sequence sites (7). A different
approach was proposed by Pond et al. who introduced a
phylogenetic maximum likelihood test based on a protein
evolution model to test for directional evolution at indi-
vidual sites of an alignment (8,9). Further related methods
quantify the impact of ‘key innovations’ in species trees,
e.g. what would happen if lineages that have acquired a
beneﬁcial feature were able to spread faster than others.
These methods incorporate clade sizes and shifts in diver-
siﬁcation rates identiﬁed from the phylogenetic tree based
on likelihood estimators in the analysis. For an overview,
see (10). However, these methods were conceived for
species-level and not population-level analysis, and
to evaluate macro-evolution. The method we describe
here does not use dN/dS information and is designed for
the analysis of longitudinally sampled population-level
sequence data. In this sense, it complements the existing
approaches.
Background on inﬂuenza A viruses
The inﬂuenza virus is a rapidly evolving pathogen that is
suited for the application of phylodynamic techniques.
The single-stranded negative-sense RNA viruses of the
family Orthomyxoviridae are a major health risk in
modern life, responsible for up to 500000 deaths
annually (11). Three distinct genera (types A, B and C)
are endemic in the human population. Types B and C
evolve slowly and circulate at low levels. However,
through rapid evolution of the antibody-binding
(epitope) sites of the surface proteins, inﬂuenza A continu-
ously evades host immunity from previous infection or
vaccination, and regularly causes large epidemics.
Inﬂuenza A viruses can furthermore be distinguished
based on the surface proteins hemagglutinin (HA) and
neuraminidase (NA). For type A viruses, 16 known
subtypes of HA and nine of NA occur in various combin-
ations in aquatic birds (12). In the human population,
inﬂuenza A viruses of the subtypes H3N2 and H1N1 cur-
rently circulate. Of these, the swine-origin inﬂuenza A
(H1N1) virus (‘swine ﬂu’), which entered the human popu-
lation in 2009, is currently responsible for the majority of
infections (13,14).
Human inﬂuenza A viruses continuously change
antigenically in a process known as antigenic drift. This
refers to the successive ﬁxation of mutations that affect
viral ﬁtness by increasing a virus’ ability to circumvent
host immunity and protective antibodies elicited by previ-
ously circulating viral variants (6,15). Antigenically
relevant changes are located mainly in the epitope sites
of the viral HA (16–19). Inﬂuenza viruses also have a seg-
mented genome composed of eight distinct segments and
can evolve by means of reassortment. In segment
reassortment, new viral strains are generated, which can
inherit genomic segments from two distinct viruses simul-
taneously infecting the same host cell. This mechanism can
affect antigenic evolution, as segments encoding
antigenically novel surface proteins, but which are
harbored by viruses with low overall ﬁtness due to other
reasons, and can thus be transferred into a more favorable
genetic context and subsequently rise to predominance
(20–25).
Antigenically novel strains of inﬂuenza A appear and
become predominant in worldwide epidemics on a regular
basis, which requires frequent adaptation of the inﬂuenza
vaccine composition. The World Health Organization
(WHO) monitors the genetic and antigenic characteristics
of the circulating inﬂuenza A virus population and
searches for antigenically novel emerging strains in a
global surveillance program (26,27). The gathered
surveillance information, combined with human serologic-
al data, is evaluated by a panel of experts. The panel
meets twice a year to decide if an update of the vaccine
composition for the next winter season for both the
Northern and Southern hemispheres is necessary. This
approach results in a well-matched vaccine in most
years, and signiﬁcantly reduces the morbidity and mortal-
ity of seasonal inﬂuenza epidemics. However, a decreased
vaccine efﬁcacy can be caused by a new antigenic variant
if it is identiﬁed too late to reformulate the vaccine
composition.
A large body of work exists on computational studies of
inﬂuenza A virus evolution. Phylogenetic reconstruction
plays a key role here, since it was successfully used to
unravel the global migration of human inﬂuenza A
(H3N2) viruses (28) and to identify East and Southeast
Asia as a global evolutionary reservoir of seasonal inﬂu-
enza A (H3N2) viruses (29). Furthermore, genome-wide
phylogenetic analysis of all eight viral segments
determined that the evolutionary dynamics of inﬂuenza
A (H3N2) virus are shaped by a complex interplay
between genetic and epidemiological factors, such as
mutation, reassortment, natural selection and gene
ﬂow (30).
Besides these analytical studies, further computational
methods have been applied to study and predict the evo-
lution of human inﬂuenza A (H3N2) viruses. Changes
within the hemagglutinin HA1 subunit sequence compos-
ition over time were visualized and analyzed by Shih et al.
using amino acid frequency diagrams (31). However, this
procedure does not take the underlying evolutionary rela-
tionships and structure of the data into account, as isolate
sequences and individual sites are treated independently.
Plotkin et al. used agglomerative single-linkage clustering
on hemagglutinin HA1 genetic sequences for decomposing
the data into disjoint clusters, ﬁnding that inﬂuenza evo-
lution is characterized by a succession of predominant
clusters or ‘swarms’ of similar strains (32). This pattern
is also reﬂected by a narrow phylogenetic tree topology
with one surviving viral lineage over time and a viral di-
versity that is periodically diminished by selective sweeps
of a novel viral strain throughout the population (11,30).
Analyzing the cluster size–time relation, Plotkin et al. sug-
gested using a representative of the largest cluster as the
vaccine strain for the following winter season (32).
Du et al. constructed a co-occurrence network from
co-occurring nucleotides across the whole genome (33).
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changes, and used these co-occurrence modules for
sequence clustering. This results in a grouping similar to
the structure inferred by phylogenetic reconstruction. Xia
et al. used mutual information to identify and visualize
co-occurring mutations in a ‘site transition network’
(34). They also used this network to predict future muta-
tions, resulting in 70% sensitivity but also in a rather high
false positive rate. However, it should be noted that,
although the term ‘predicting mutations’ may convey
that mutations are introduced independently in viral
isolates in the following season, the effect that a particular
genetic change increases in frequency over two consecutive
seasons is often due to a previously low-abundance
mutant circulating at higher prevalence.
Most of the abovementioned studies assess the
underlying evolutionary relationships and structure for
the population-level sequence sample in some way.
However, the standard way to estimate evolutionary rela-
tionships is by phylogenetic inference. As described above,
Bush et al. identiﬁed 18 sites under positive selection by
analyzing the ratio of dN/dS on the trunk of a phylogen-
etic tree of hemagglutinin HA1 subunit sequences (6).
They subsequently used these sites to predict the direction
of evolution for a phylogenetic tree of inﬂuenza A (H3N2)
virus HA by identifying the strains within the phylogenetic
tree that had the most pronounced evidence for positive
selection (35). However, the dN/dS ratio lacks sensitivity if
applied to individual sites, as substantial evidence is
required for a site to be considered informative. Not all
relevant sites may thus be detectable and, furthermore, the
most relevant sites may change over time (15). In a more
recent study, Pond et al. identiﬁed nine sites as being
under directional selection in the HA segment of the in-
ﬂuenza A (H3N2) virus, using a model-based phylogenetic
maximum likelihood test. Seven of these sites are not
detected with the traditional dN/dS ratio test (9).
Nevertheless, this method depends on the baseline
amino-acid-substitution matrix and failed to identify
adaptive sites when applied to dim-light and color-vision
genes in vertebrates (36).
To analyze the antigenic evolution of inﬂuenza A
viruses, Smith et al. introduced a novel method known
as antigenic cartography, which is based on multidimen-
sional scaling of assay data on hemagglutination inhib-
ition (15,37). This technique revealed that antigenic
evolution is more clustered than genetic evolution, de-
pending on the antigenic impact of individual amino
acid exchanges, and that major changes (cluster jumps)
occur every 3–4 years on average (15). Accordingly,
including both antigenic and genetic data within evolu-
tionary models enables the most accurate analysis of in-
ﬂuenza A virus evolution. Some studies try to incorporate
antigenic data (38–40); however, because of limited
publicly available data, the results have to be approached
with caution. To account for this lack of antigenic infor-
mation for the respective isolate sequences in our evalu-
ation, we identiﬁed all predominant antigenic variants
over the analyzed time period based on the genetic
changes reported in the literature.
MATERIALS AND METHODS
Phylogenetic inference
HA sequences from 4913 seasonal human inﬂuenza A
(H3N2) virus isolates sampled from 1988 to 2008, and
from 1516 swine-origin inﬂuenza A (H1N1) virus
isolates with exact sampling times (year and month)
were downloaded from the inﬂuenza virus resource (41)
(Supplementary Tables S1 and S2). Alignments of DNA
and protein sequences were created with Muscle (42) and
manually curated. Phylogenetic trees were inferred with
PhyML v3.0 (43) under the general time reversal
GTR+I+4 model, with the frequency of each substitu-
tion type, the proportion of invariant sites (I) and the
gamma distribution of among-site rate variation, with
four rate categories (4), estimated from the data.
Subsequently, the tree topology and branch lengths of
the maximum likelihood tree inferred with PhyML were
optimized for 200000 generations with Garli v0.96b8 (44).
Allele dynamics plots
We describe AD plots for visualizing the evolutionary
dynamics of a gene in a population and for identifying
the alleles that are potentially under directional selection.
In a nutshell, AD plots visualize gene alleles and their
frequencies over time and thus enable a detailed analysis
of a gene in a population. The basic idea involves the
following four steps: (i) Inference of the evolutionary re-
lationships for a sequence sample of a population. (ii)
Ancestral character state reconstruction and inference of
evolutionary intermediates based on the reconstructed
evolutionary relationships. (iii) Mapping genetic changes
to branches of the tree topology and deﬁning the preva-
lence of distinct alleles of a gene at different points in time.
(iv) Finally, evaluating how fast new alleles or genetic
variants propagate throughout the population.
Population genetics theory posits that, in a population
of constant size, genetic drift will result in variation in
allele frequencies and the continuous ﬁxation of variants
even in the absence of selection (45–47). However, given
that selection acts on an allele and confers a ﬁtness advan-
tage to the individual organism, this will allow such alleles
to rise faster in frequency than alleles without a selective
advantage. Hence, alleles that increase in frequency most
rapidly over time are more likely to be subject to direc-
tional selection than other alleles. This criterion can be
applied to identify those alleles that might be associated
with a selective advantage from AD plots.
Following the phylogenetic inference of a tree topology
using any standard method [maximum likelihood,
Neighbor-Joining or a consensus tree constructed from a
posterior sample of trees inferred with a Bayesian method
(48,49)], substitution events in the evolutionary history are
reconstructed using ancestral character state reconstruc-
tion and assigned to individual tree branches. In detail,
substitution events are assigned to the tree branches
based on the evolutionary intermediates reconstructed as
ancestral characters. We use the parsimony method of
Fitch et al. (50) for ancestral character state reconstruc-
tion; however, in principle, any available method can be
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the earliest sampling date as an outgroup and used
accelerated transformation (AccTran) (51) to resolve
ambiguities in character state reconstruction. This proced-
ure results in changes being mapped preferentially closer
to the root of the phylogenetic tree.
We deﬁne each branch that is associated with a
non-empty set of substitutions to represent an individual
allele. The number of alleles thus equals the number of
branches with non-empty sets of substitutions in the
phylogenetic tree. We deﬁne the frequency of an allele
within a speciﬁc period as the ratio of the number of
isolates in the subtree of the allele relative to the number
of all isolates within the designated period. An allele that
occurs later on the path from the root to the most recent
isolates includes the substitutions of the alleles that
occurred earlier on this path and thus is more speciﬁc.
Allelic frequencies are subsequently adjusted in case
multiple related alleles emerge within the same period.
Isolates located in the subtrees of a newly deﬁned allele
within a period are counted only once for the most closely
placed parental allele in the phylogenetic tree. This means
that, for calculating the allele frequency of all less speciﬁc
alleles, isolates that occur in the subtree below the more
speciﬁc allele are not considered. Alleles and the relevant
substitutions are discussed using the following nomencla-
ture: allele substitutions *substitutions of parental alleles
from the same period* (Figure 1).
Construction of AD plots for human inﬂuenza A viruses
In analyzing the evolution of human inﬂuenza A viruses,
we are particularly interested in those changes that affect
the antigenic properties of a virus. To identify viral
variants with increased ﬁtness for propagation through
the host population, non-synonymous genetic changes of
HA are of particular interest. To this end, we constructed
AD plots from the substitutions for the complete viral HA
of the inﬂuenza A (H1N1) virus. Secondly, we constructed
AD plots for the seasonal inﬂuenza A (H3N2) virus based
on the changes in the ﬁve epitope regions of HA (16,17).
Inﬂuenza infections in the human population show a
pattern of seasonality. Peaks of activity occur mainly in
the winter months in temperate regions of each hemi-
sphere (53). We use the standard deﬁnitions for the inﬂu-
enza season for the Northern and Southern hemispheres in
our analysis. For the Northern hemisphere, the inﬂuenza
season begins on 1 October and ends on 31 March in the
following year. For the Southern hemisphere, the inﬂu-
enza season begins on 1 April and ends on 30 September
in the same year. For a comparison with the WHO vaccine
strain recommendation, we restricted our analysis to
sequences sampled up to the end of January for the
Northern hemisphere season and to the end of August
for the Southern hemisphere season, which is when the
WHO decides on the vaccine composition.
To identify the alleles corresponding to the viral strains
with antigenically novel HA variants, we used the litera-
ture to determine the genetic changes reported for every
predominant antigenic variant over the analysis period.
These appear, on average, every 3.3 years and then pre-
dominate worldwide in seasonal epidemics (15). The
changes in these strains for the ﬁve HA epitopes are
given in Table 1.
RESULTS
Evolutionary dynamics of inﬂuenza A (H3N2)
We analyze the evolutionary dynamics of the seasonal in-
ﬂuenza A (H3N2) virus with AD plots generated using a
maximum likelihood tree (Figure 2) from available HA
sequences. The H3N2 subtype has been circulating since
1968, but here we focus on the time from 1998 until the
end of 2008. For this more recent period, there is consid-
erably more sequence data available and the bias of se-
quences toward isolates with unusual virulence or other
atypical properties is reduced (54) (Supplementary
Figure S3).
The AD plot for HA of the human H3N2 virus
(Figure 3, Supplementary Figure S1) shows several
alleles that rise to predominance and reach ﬁxation
(their frequency in subsequent periods equals one)
between 1998 and 2008, such as 57Q *137S*, 156H
*75Q, 155T* and 193F. Other alleles reach high
frequencies and subsequently vanish, such as 160R in the
1999 Southern season, 273S in the 2000/01 Northern
season or 126D in the 2003 Southern season.
Furthermore, a lot of minor-frequency allelic variation is
evident within each period.
Alleles becoming predominant and rising to ﬁxation in
the surviving lineage correspond to substitutions that map
to the trunk of the phylogenetic tree of HA from the
human inﬂuenza A (H3N2) virus. Besides such changes,
the observable variation of alleles that do not become
ﬁxed (gray-colored alleles) is rather high within each
time interval in the analyzed sample. Although some
alleles transiently reach high frequencies, they are only
present over a short period. Notably, many of these
alleles appear during times when an antigenic variant
has been predominant for several years, such as the time





















Figure 1. A tree demonstrating the concepts of alleles and allele fre-
quency correction. For allele 100A, only the isolates of subtree x are
counted, whereas for allele 200B *100A*, the isolates in subtree y are
considered.
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alleles with similar antigenic properties, such as 160R in
the 1999 Southern season, 92T in the 1999/2000 Northern
season, 273S and 50G, 247C in the 2000/01
Northern season, and 144D *186G* in the 2001/02
Northern season, (55–58) appeared successively and rose
to high frequencies without reaching ﬁxation.
Most of the alleles rising to ﬁxation (colored in
Figure 3) are associated with substitutions reported in
the literature (59–63) for the ﬁve distinct strains that rep-
resent predominant antigenic variants in the analysis
period (Table 1). Note that the substitutions of a particu-
lar antigenic variant are not necessarily all part of the
same allele (i.e. they do not map to the same branch on
the trunk of the phylogenetic tree). Instead, they often
follow each other in immediate succession in the AD
plot and are located on consecutive trunk branches of
the phylogenetic tree. The earliest antigenic variant of
the analysis period (PA99) is an exception, in this sense,
as a single allele represents multiple substitutions. This
reveals the limitations of the dataset for the earlier years
(Supplementary Figure S3), which does not allow the
order in which the PA99 substitutions were acquired by
H3N2 to be resolved. For all subsequent antigenic
variants, the order of the acquired substitutions is
resolved and a set of multiple alleles becoming ﬁxed
within an interval are evident from the AD plot. Thus,
the evolutionary path and the order in which these
changes were acquired in the evolution of antigenically
new strains of H3N2 are revealed in the AD plot. For
instance, for the antigenic variant BR07, which was pre-
dominant from 2006 to 2009, the HA plot shows that, of
the two relevant substitutions, 140I was acquired ﬁrst,
followed by 50E.
Figure 2. Maximum likelihood tree topology inferred for 4913 hemagglutinin sequences of seasonal human inﬂuenza A (H3N2). Leaf nodes are
color-coded according to the sampling dates of the viral isolates. The ﬁrst sampled isolate, A/Siena/3/1988, is indicated with an arrow. The trunk of
the tree (i.e. the path from the root to the most recent clade) is colored in red.
Table 1. Antigenically novel viral variants of inﬂuenza A (H3N2) that emerged and rose to predominance in worldwide epidemics between 1998
and 2008, and the corresponding substitutions reported in the literature in the ﬁve epitope sites of HA
Antigenic cluster Substitutions Reference
A/Sydney/5/1997 (SY95) 62E, 156Q, 158K, 196A, 276K (59)
A/Moscow/10/1999 (MO99) 57Q, 137S (59)
A/Panama/2007/1999 (PA99) 144N, 172E, 192I (59)
A/Fujian/411/2002 (FU02) 50G, 75Q, 83K, 131T, 155T, 156H, 186G (60)
A/California/07/2004 (CA04) 145N, 159F, 189N, 226I, 227P (61)
A/Wisconsin/67/2005 (WI05) 193F (62)
A/Brisbane/10/2007 (BR07) 50E, 140I (63)
Note that PA99 is antigenically similar to MO99 and was used as the vaccine candidate strain for MO99 (56).
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inﬂuenza A (H3N2)
The AD plot, which visualizes the changes in frequencies
of individual alleles in a sequence sample, enables us to
easily identify those alleles that increase in prevalence
most rapidly over two consecutive inﬂuenza seasons.
The corresponding viral strains are likely candidates to
be under the inﬂuence of directional selection and to
have an advantage relative to other alleles. We identiﬁed
the alleles with the largest increase in frequency between
consecutive seasons that do not represent >50% of the
sequences in the ﬁrst season (otherwise they would
already be predominant; Table 1). Of the strains of the
ﬁve antigenically distinct predominant variants
(MO99/PA99, FU02, CA04, WI05 and BR07), four can
be correctly identiﬁed by this criterion (Table 2). Thus,
this measure allows us to use the AD plots to easily
identify the strains that are most relevant when deciding
the composition of the inﬂuenza A (H3N2) vaccine.
In the 1998/99 Northern season, the allele that scores
best is 57Q *137S*, which represents the MO99 variant
that was predominant from the 1999 Southern season to
the 2002–03 Northern season (55–58,64–67). The allele
144N *172E, 192I*, which represents the antigenically
very similar strain PA99, ranks second best. In agreement
with the AD plot observations, the WHO also
recommended MO99 as the vaccine strain for the 2000
Southern season (55). As no suitable well-growing candi-
date strain could be produced, the previously predominant
SY97 strain was used in this season for the vaccine. PA99
was subsequently included as a vaccine component
starting from the 1999–2000 Northern season (56). Thus,
for the SY97-PA99 antigenic cluster transition, the AD
plot allows the timely identiﬁcation of a suitable strain
that is in agreement with the original recommendation
of the WHO.
The FU02 variant, which predominated from 2003 to
2004/05 (68–71), is associated with seven distinct substitu-
tions: 50G, 75Q, 83K, 131T, 155T, 156H and 186G. The
155T and 156H deﬁne the FU02 antigenic phenotype (72).
In the AD plot, the seven FU02 substitutions are
associated with seven distinct alleles, each with a single
substitution. In the 2002–03 Northern season, alleles
with the substitutions 131T *186G* and 156H *75Q,
155T* score ﬁrst and second best, respectively. The best
scoring allele for the 2002/03 Northern season lacks the
relevant substitutions 155T and 156H described for FU02.
Here, the frequency indicator does not directly reveal the
best candidate strain based on the available data.
Antigenic information would probably allow a more
detailed analysis. The second high-scoring allele would
presumably be a good choice as a vaccine strain, as it
Figure 3. Allele dynamics plot for the major surface protein and antigenic determinant of the seasonal inﬂuenza A (H3N2) virus. The Northern and
Southern inﬂuenza seasons from 1998 to 2008 are shown. Alleles that reach a prevalence of more than 95% and are subsequently ﬁxed are shown in
color; all other alleles are shown in gray. Substitutions are restricted to those that occur in the ﬁve epitope regions and are enumerated according to
HA1 numbering (86). Alleles that rise most quickly in frequency and are of interest with respect to vaccine strain selection are indicated by arrows.
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increase in prevalence during the season. In agreement
with this conjecture, the corresponding strain (A/Fujian/
411/2002) was recommended by the WHO as the vaccine
strain for the 2003–04 Northern season (67). However, as
no suitable well-growing candidate strain could be
produced, the MO99/PA99 strain was used for the
vaccine. In the 2002 Southern season, the 155T *75Q*
allele ranks ﬁrst, but the correct allele (156H *75Q,
155T*), which features all necessary substitutions, in-
creases only a little in frequency and is thus not selected.
Interestingly, an additional substitution (186G) found
in the highest scoring allele for the 2002–03 Northern
season appears independently in another frequent allele
in the preceding season. This seems a general aspect of
H3N2 evolution—the repeated appearance of the same
substitution in multiple different alleles. Often, the re-
spective alleles have different phylogenetic histories, in
that they occur in different parts of the tree, and the sub-
stitutions are occasionally encoded by different codons.
Such repeated changes can either reﬂect neutral changes
at highly variable sequence positions or they can be the
result of directional selection against a certain residue at a
given position at this time. The AD plot allows us to
identify such changes easily for further analysis.
The CA04 variant was predominant from 2004–05 to
2005–06 (73,74) and was recommended as vaccine strain
for the 2005–06 Northern season in the spring of 2005
(71). The HA allele of this strain scores highest in the
2004 Southern season. Here, the two alleles featuring the
substitutions 145N *159F, 226I* and 227P *189N*, re-
spectively, rank ﬁrst and second. Both of these alleles
contain substitutions of the CA04 variant, but only the
top-ranking one possesses all relevant substitutions and
thus is the correct choice.
The WI05 variant predominated from 2006 to 2006–07
(74,75) and was recommended one season too late as the
vaccine strain for the 2006–07 Northern season (76). In the
2005 Southern season, the 193F allele associated with the
WI05 variant scores highest. The second substitution
associated with WI05, 225N, is not evident from this
plot, as it is not part of the epitope regions. If non-epitope
sites are included in the analysis, both substitutions appear
on subsequent branches, corresponding to two consecu-
tive emerging alleles in the plot (data not shown). In this
plot, the allele 225N *193F* scores highest. The AD plot
thus allows us to identify the WI05 variant from the avail-
able data one season before the WHO’s ofﬁcial
recommendation.
Finally, the antigenic variant BR07, which pre-
dominated from 2007 onwards (13,77–79), scores highest
in the 2006–07 Northern season and is represented by an
allele with the substitutions 50E *140I*. A matching strain
was recommended for the vaccine of the 2008 Southern
season (77). The AD plot allows us to identify this
emerging variant for the 2007–08 Northern season.
Applying a maximum likelihood test for directional
evolution of protein sequences (DEPS) (9) to the HA
data of H3N2 from 1988 to 2008 revealed 42 sites in the
HA epitopes. Nine of these sites are also under positive
selection according to a dN/dS ratio test (8) (data not
shown). However, of the 20 epitope sites where changes
rise to ﬁxation over the analysis period (Figure 2), only 12
are detected by the DEPS method (Supplementary Table
S3). This highlights that such rapidly ﬁxed changes cannot
all be identiﬁed by common selection tests.
Retrospectively, our approach allows the identiﬁcation
of the CA04/WI05 antigenic cluster transition in the 2005
Southern season, one year before it rises to predominance
in the 2006 season (Figure 6). In all other cases, our
method allows us to identify the correct strain one
season before the respective antigenic variant becomes
predominant: The SY97/MO99 transition is detected in
the 1998–99 Northern hemisphere season, while the
MO99 variant became predominant in the 1999
Southern hemisphere season. The FU02/CA04 transition
Table 2. Alleles and their associated antigenic phenotypes with the steepest slopes in the seasons when they are predicted to become
predominant
Season Alleles Slope Antigenic variant WHO Predominant
1998/99 North 57Q *137S* 0.5027 MO99 SY97 (80) MO99/PA99 (56)
144N *172E, 192I* 0.3704 PA99
2002 South 155T *75Q* 0.0833 FU02 MO99 (58) FU02 (68)
131T *186G* 0.0797 FU02
83K 0.0594 HK02/FU02
50G 0.0485 HK02/FU02
2002/03 North 131T *186G* 0.6616 FU02 FU02 (67) FU02 (69)
156H *75Q, 155T* 0.6546 FU02
83K 0.5950 HK02/FU02
50G 0.5950 HK02/FU02
2004 South 145N *159F, 226I* 0.3828 WE04/CA04 WE04 (69) CA04 (73)
227P *189N* 0.3331 WE04/CA04
2005 South 193F 0.5350 WI05 CA04 (73) WI05 (74)
2006/07 North 50E *140I* 0.1389 BR07 WI05 (75) BR07 (78)
Alleles in one season are ordered by decreasing slope. Further comparisons show the recommended reference strain for the use in the next year’s
vaccine by the WHO and the predominant antigenic variant in the next year’s inﬂuenza season for the same hemisphere. Note that A/Hong Kong/
1143/2002 (HK02, [50G, 83K, 186G]) is a PA99-like sublineage present before FU02 and A/Wellington/1/2004 (WE04, [159F, 189N, 227P]) was
directly replaced by CA04 in 2004/05 Northern season before becoming predominant.
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CA04 became predominant in the 2004–05 Northern
season. Finally, the WI05/BR07 transition is identiﬁed in
the 2006–07 Northern season, while the BR07 antigenic
variant became predominant in the 2007 Southern season.
In comparison to the WHO recommendations
(13,14,55–58,64–71,73–80), this approach identiﬁes the
newly emerging variants one season earlier. This may be
because the WHO tends to be conservative in recommen-
dations, to avoid suggesting an antigenic variant that may
never actually rise to predominance in the future.
However, in general, new variants reach predominance
very rapidly, if the time from the ﬁrst appearance in the
available genetic sequences is measured. In all three cases
mentioned above, the new variant rose to predominance
after its ﬁrst appearance within a single year. Thus, given
the available data, predicting this event one year ahead of
time would be impossible. Fortunately, in some cases the
antigenic changes between successive variants are not that
large (15,37). For instance, MO99 was antigenically
similar to SY97. Thus, even though most isolates
sampled in the 1999 Southern season reacted to a higher
titer with the ferret antisera raised against MO99 (55),
recommending SY97 for the vaccine composition thus
did not result in a dramatically lower vaccine efﬁcacy.
Inﬂuence of timing on antigenic variant identiﬁcation
Twice a year, in February and September, vaccine strains
are recommended for inﬂuenza B, inﬂuenza A (H3N2) and
inﬂuenza A (H1N1) to the manufacturers of the seasonal
inﬂuenza vaccine. This recommendation is made approxi-
mately one year before the vaccine will be used in the
Northern or Southern seasons, respectively (27). Above,
we analyzed the data available only up to that point. If we
use all available data until the end of the inﬂuenza
seasons, emerging alleles appear at high frequencies in
the respective AD plot. For example, this happened for
the BR07 allele in the 2006–07 Northern hemisphere
season (Figure 3, Supplementary Figure S2). Previously
circulating strains, on the other hand, occur at lower
frequencies in comparison, as newly emerging antigenic
variants increase in prevalence typically toward the end
of a season. This effect is more pronounced for the
Northern hemisphere than for the Southern hemisphere,
possibly because after the vaccine meeting in the Northern
hemisphere, two months of the winter season are still to
follow, whereas only one month of winter still remains in
the Southern hemisphere. However, overall the picture
remains very similar. Based on all available data, all ﬁve
antigenic variants can be identiﬁed based on their rapid
increase in prevalence. A noteworthy difference is evident
only for the 2002–03 Northern season, where the 156H
*75Q, 155T* allele of the emerging FU02 antigenic
variant now ranks ﬁrst. In summary, limiting the data to
what is available by the time of the WHO vaccine
meetings, reduces the frequency of alleles associated with
newly emerging variants in the AD plot, but the ability to
identify viral strains that subsequently rise to predomin-
ance is preserved in four out of ﬁve cases.
Evolutionary dynamics of the inﬂuenza A (H1N1) virus
We next studied the evolutionary dynamics of the 2009
inﬂuenza A (H1N1) virus, using 1516 available, exactly
dated HA sequences (Figure 4). The virus has circulated
in the human population only since April 2009 (81–83).
Therefore, we have studied the evolutionary dynamics in
monthly intervals (Figure 5, Supplementary Figure S4).
As isolate A/California/05/2009 was the only one
sampled in March, it was assigned to 1 April to avoid
errors introduced through the small sample size for
March 2009. The AD plots show that one
non-synonymous and another synonymous change
become ﬁxed over the analysis period. The corresponding
substitutions, T658A [encoding the S206T change (H3
HA1 numbering)] and C1408T (encoding a synonymous
substitution for leucine), have already been reported to
divide the sequenced isolates into two distinct clusters
(84), but have no known antigenic impact (81).
Furthermore, Pan et al. have already reported an
increase in allele frequency for the S206T substitution
among new H1N1 sequence isolates (85).
Besides these changes, the plot also reveals the existence
of several other alleles, which, so far, appear only at low
frequencies and did not become ﬁxed until December of
2009. Despite the fact that the data currently is very
limited, at this point, the plots do not reveal any alleles
or associated substitutions that seem to be on the rise.
Thus, based on the available data, the virus currently
seems stable in terms of antigenicity, indicating that no
update of the vaccine strain for this virus will be
required for the 2010–11 season [also reported by the
WHO (14)]. However, some caution is warranted in this
interpretation, as different months are represented very
unevenly, with lots of data from April and May of 2009
and much less from the following months (Supplementary
Figure S5).
DEPS analysis of the H1N1 data identiﬁes ﬁve sites in
HA with evidence for directional evolution. Three of these
sites are also predicted to be under positive selection based
on a dN/dS ratio test (Supplementary Table S4). This
includes position 206, where a non-synonymous change
has become ﬁxed within the analysis period (220 in H1
sequence numbering). This indicates that this site might
have been under positive selection and that several further
sites could be of relevance for the future evolution of
H1N1. However, overall, these results should be taken
with care, as the analysis period of 1year, during which
extensive sampling has taken place, is rather short, and the
data might be more enriched than samples obtained over
longer periods, with many neutral or slightly deleterious
mutations.
CONCLUSIONS
AD plots provide a simple and easy to interpret visualiza-
tion of the evolutionary dynamics of a gene within a popu-
lation from a sample of dated genetic sequences. This
is particularly helpful for the analysis of large-scale
sequence datasets, where a standard visualization such
as a phylogenetic tree topology is difﬁcult to interpret
e4 Nucleic AcidsResearch, 2011,Vol. 39,No. 1 PAGE 8 OF 12manually and does not directly display sampling times.
Here, we have applied our method to investigate the evo-
lutionary dynamics of seasonal inﬂuenza A H3N2 and
H1N1 viruses, for which available sequence data is
abundant.
From the AD plot for inﬂuenza A (H3N2), one can
easily determine the order in which substitutions of the
surviving lineage became ﬁxed over the analysis period,
and one can identify the predominant antigenic variants
between 1998 and 2008. Furthermore, we propose a novel
indicator for directional selection, which allows us to
identify the alleles and corresponding substitutions that
might have a selective advantage. We demonstrate this
approach for identifying future predominant and novel
viral strains. With this method, strains for four out of
ﬁve antigenic phenotype transitions in inﬂuenza A
(H3N2) evolution can be identiﬁed, based on the data
available up to the time of the WHO vaccine strain
meeting. One limitation for this application is the fact
that a particular allele may score best for every time
period, with no information on whether it is antigenically
similar or different from the current vaccine strain.
Hence, antigenic information also has to be considered to
decide whether a vaccine update is warranted. In summary,
AD plots enable a sensitive and timely method for detecting
emerging viral strains that rise to high frequencies in sub-
sequent seasons. In our analysis, we ﬁnd that AD plots
permit us to accurately identify those alleles that subse-
quently rise to predominance and become ﬁxed in the
course of viral evolution. In combination with antigenic
information on the individual strains, AD plots thus
present a new tool for the detailed analysis of inﬂuenza
surveillance data that could be used in the selection of
strains for the seasonal inﬂuenza A virus vaccine.
Secondly, we used AD plots to analyze the evolutionary
dynamics of the 2009 inﬂuenza A (H1N1) virus. The AD
plot for this virus reveals several new variants with unique
genetic composition that circulate at low levels in the
human population and two genetic changes that became
ﬁxed in the period from April to December 2009. At this
point, the plot does not allow identiﬁcation of any further
genetic changes that may become ﬁxed in the near future,
indicating that the virus currently is evolutionarily stable,
even though data is limited.
Figure 4. Maximum likelihood tree topology inferred from 1516 2009 swine-origin inﬂuenza A (H1N1) hemagglutinin sequences. Leaf nodes are
color-coded according to the sampling dates of the viral isolates. The ﬁrst sampled isolate, A/California/05/2009, is indicated with an arrow.
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for the study of longitudinal population-level sequence
samples and for the identiﬁcation of alleles that are on
the rise to predominance. The method allows us to inves-
tigate the evolutionary dynamics of rapidly evolving
populations, under consideration of the inherent evolu-
tionary relationships and structure of the data. It comple-
ments existing methods for detecting sites under
directional and positive selection, such as dN/dS ratio
tests or DEPS. Note that AD plots are not limited to
the study of inﬂuenza A viruses, but can also be applied
for the analysis of other fast-evolving populations, such as
the intra-host evolution of human immunodeﬁciency or
hepatitis C viruses. Generally, the best results are likely
to be obtained if the analyzed sequence sample is repre-
sentative for a constant-sized population without too
much structure (e.g. geographic subdivisions). In this
case, variations in frequencies can be taken as estimates
for the evolutionary dynamics of the respective popula-
tion. Finally, while many computational techniques have
been applied to predict the evolutionary dynamics of in-
ﬂuenza A viruses, our method integrates state-of-the-art
Figure 5. Allele dynamics plot for the major surface protein and antigenic determinant of the new inﬂuenza A (H1N1) based on sequences sampled
between April and December of 2009 without allele frequency correction. Alleles that reach a prevalence of more than 95% and are subsequently
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Figure 6. Comparison of predominant inﬂuenza A (H3N2) strains, WHO vaccine strain recommendations and strains identiﬁed by AD plot analysis.
For the AD plot analysis, seasons with antigenic cluster transitions are shown in color. The information shown for the AD plot and the WHO
recommendation represents the selection made 1year earlier.
e4 Nucleic AcidsResearch, 2011,Vol. 39,No. 1 PAGE 10 OF 12phylogenetic inference, ancestral state reconstruction and
a novel indicator of directional selection into the analysis,
and thus provides a solution with extensive theoretical
support.
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